Madrigal Pharmaceuticals Inc. (MDGL) Live Share Price, Invest From India

Madrigal Pharmaceuticals Inc. Stock Performance

as on August 1, 2026 at 2:16 pm IST

Day's Low
Day's High
$460.11
Day's Price Range
$487.73
$467.32
1.54%
Downside
4.37%
Upside
52 Week's Low
52 Week's High
$298.00
52-Week Price Range
$615.00
$467.32
36.23%
Downside
31.60%
Upside

Madrigal Pharmaceuticals Inc. share price movements today

Previous Close: $493.11
Open: $487.73
Volume: 758.8K
Day's Low - High: $460.11 - $487.73
52 Week Low - High: $298.00 - $615.00

Madrigal Pharmaceuticals Inc. Historical Returns

1 Month Return: -11.51 %
3 Month Return: -9.03 %
1 Year Return: + 54.65 %
3 Year Return: + 135.46 %
5 Year Return: + 431.53 %

Madrigal Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Madrigal Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.4B

EPS (TTM)

-6.63

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-321.1M

Revenue (TTM)

1.3B

Profit Margin

-25.32%

Return On Equity TTM

-53.31%

Madrigal Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Madrigal Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Madrigal Pharmaceuticals Inc.	BUY	$11.4B	431.53%	NA	-25.32%	NA
Revolution Medicines Inc.	BUY	$40.9B	539.16%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.3B	140.57%	28.66	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$76.0B	32.14%	16.98	29.65%	NA

Stock Returns calculator for Madrigal Pharmaceuticals Inc. Stock including INR - Dollar returns

The Madrigal Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Madrigal Pharmaceuticals Inc. investment value today

Current value as on today

₹1,69,093

Returns

₹69,093

(+69.09%)

Returns from Madrigal Pharmaceuticals Inc. Stock

₹54,655 (+54.65%)

Dollar Impact

₹14,438 (+14.44%)

Analyst Recommendation on Madrigal Pharmaceuticals Inc. Stock

Based on 21 analysts

BUY

80.95%

Buy

14.29%

Hold

4.76%

Sell

Based on 21 analysts, 80.95% of analysts recommend a 'BUY' rating for Madrigal Pharmaceuticals Inc.. Average target price of $681.8

Madrigal Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Madrigal Pharmaceuticals Inc..

What analysts predicted

31.46%UPSIDE

Target Price

$681.8

Current Price

$467.32

Analyzed by

21 Analysts

Target

$681.80

Madrigal Pharmaceuticals Inc. target price $681.8, a slight upside of 31.46% compared to current price of $467.32. According to 21 analysts rating.

Madrigal Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	14	62	103	137	212	287	321	311
Gross Profit	0	0	14	60	99	132	203	269	296	284
Operating Income	-117	-152	-162	-116	-66	-79	-47	-113	-59	-92
EBITDA	-108	-143	-148	-102	-55	-69	-38	-106	-49	-86
Interest Expense	3	3	3	3	3	3	3	7	8	7
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-112	-147	-151	-106	-59	-73	-42	-114	-58	-94
Income Tax Expense	0	0	-	0	-	-	-	-	-	-
Net Income	-112	-147	-151	-106	-59	-73	-42	-114	-58	-94
Net Profit Margin	0.00%	0.00%	-1038.20%	-172.04%	-57.51%	-53.36%	-19.87%	-39.75%	-18.24%	-30.32%

Madrigal Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	-	-	-	-	-	-	180	958
Gross Profit	0	0	0	0	0	-	-	-	173	902
Operating Income	-25	-32	-40	-94	-206	-242	-293	-380	-497	-300
EBITDA	-25	-31	-40	-94	-206	-242	-290	-360	-450	-264
Interest Expense	1	0	7	11	4	1	3	12	14	22
Depreciation	-	0	0	0	0	0	0	0	1	1
Income Before Tax	-26	-31	-32	-83	-202	-241	-295	-373	-465	-288
Income Tax Expense	0	0	7	-11	-4	0	3	-	-465	-
Net Income	-26	-31	-32	-72	-197	-241	-295	-373	-465	-288
Net Profit Margin	0.00%	-8901.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-258.64%	-30.08%

Madrigal Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-147	-151	-106	-59	-73	-42	-114	-58	-94
Operating Cash Flow	-149	-134	-66	-104	-88	-47	79	-133	-167
Investing Cash Flow	98	-122	-202	-47	163	47	-206	27	192
Financing Cash Flow	573	134	7	19	8	1	236	8	2
Change in Cash	522	-122	-261	-132	83	2	109	-96	28

Madrigal Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-31	-32	-83	-202	-241	-295	-373	-465	-288
Operating Cash Flow	-22	-25	-41	-157	-183	-224	-324	-455	-189
Investing Cash Flow	-22	-380	30	159	-5	206	-502	-274	32
Financing Cash Flow	173	314	0	5	171	313	595	735	255
Change in Cash	129	-91	-10	7	-17	295	-231	5	98

Global Institutional Holdings in Madrigal Pharmaceuticals Inc.

Funds	Holdings
T. Rowe Price Associates, Inc.	1.42%
Baker Bros Advisors LP	9.29%
HHG PLC	8.76%
RTW INVESTMENTS, LLC	8.65%
BlackRock Inc	6.77%

See all

Madrigal Pharmaceuticals Inc. News & Key Events

Insights on Madrigal Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 357.3%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 472.1% return, outperforming this stock by 336.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, MDGL stock has moved down by -14.2%

About Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Organisation	Madrigal Pharmaceuticals Inc.
Headquarters	Four Tower Bridge, West Conshohocken, PA, United States, 19428
Industry	Biotechnology
CEO	Mr. William J. Sibold
E-voting on shares	Click here to vote

Key Management of Madrigal Pharmaceuticals Inc.

Name	Title
Dr. Rebecca A. Taub M.D.	Founder, Senior Scientific & Medical Advisor and Director
Ms. Shannon Kelley	Executive VP, Chief Legal Officer & Corporate Secretary
Dr. David Soergel M.D.	Executive VP & Chief Medical Officer
Ms. Rita Thakkar	Senior VP & Chief Accounting Officer
Ms. Tina E. Ventura	Chief Investor Relations Officer
Mr. William J. Sibold	CEO, President & Director
Ms. Carole Huntsman	Executive VP & Chief Commercial Officer
Mr. Mark Underwood	Executive Vice President of Business Planning & Operations
Mr. Ronald Filippo	Executive VP & Chief Information Officer
Ms. Mardi C. Dier	Executive VP & CFO

FAQs

What is Madrigal Pharmaceuticals Inc. share price today?

Madrigal Pharmaceuticals Inc. share price today is $467.32 as on August 1, 2026 at 8:46 am IST at the close of the market. Madrigal Pharmaceuticals Inc. share today touched a day high of $487.73 and a low of $460.11.

What is the 52 week high and 52 week low for Madrigal Pharmaceuticals Inc. share?

Madrigal Pharmaceuticals Inc. share touched a 52 week high of $615.00 on December 24, 2025 and a 52 week low of $298.00 on August 1, 2025. Madrigal Pharmaceuticals Inc. stock price today i.e. August 1, 2026 at 8:46 am IST is closed at $467.32,which is 24.01% down from its 52 week high and 56.82% up from its 52 week low.

What is Madrigal Pharmaceuticals Inc.'s market capitalisation today?

Madrigal Pharmaceuticals Inc. market capitalisation is $0.01T as on August 1, 2026 at 8:46 am IST.

How to invest in Madrigal Pharmaceuticals Inc. Stock (MDGL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Madrigal Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Madrigal Pharmaceuticals Inc. Shares that will get you 0.0032 shares as per Madrigal Pharmaceuticals Inc. share price of $467.32 per share as on August 1, 2026 at 8:46 am IST.

What is the minimum amount required to buy Madrigal Pharmaceuticals Inc. Stock (MDGL) from India?

Indian investors can start investing in Madrigal Pharmaceuticals Inc. (MDGL) shares with as little as ₹95.39 or $1 (as of August 2, 2026 at 2:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in Madrigal Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on August 2, 2026 at 2:41 pm IST). Based on Madrigal Pharmaceuticals Inc. share’s latest price of $467.32 as on August 1, 2026 at 8:46 am IST, you will get 0.0214 shares of Madrigal Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Madrigal Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Madrigal Pharmaceuticals Inc. stock has given 431.53% share price returns and 28.64% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?